NCT00058084View on ClinicalTrials.gov

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 1, 2007

Conditions
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
Interventions
DRUG

ixabepilone

Given IV

DRUG

mitoxantrone hydrochloride

Given IV

DRUG

prednisone

Given orally

Trial Locations (1)

94143-0875

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00058084 - Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter